Abstract
The mouse monoclonal antibody (mAb) technology still represents a key source of reagents for research and clinical diagnosis, although it is relatively inefficient and expensive and therefore unsuitable for high-throughput production against a vast repertoire of antigens. In this article, we describe a protocol that combines the immunization of individual mice with complex mixtures of influenza virus strains and a microarray-based immunoassay procedure to perform a parallel screening against the viral antigens. The protocol involves testing the supernatants of somatic cell hybrids against a capture substratum containing an array of different antigens. For each fusion experiment, we carried out more than 25,000 antigen-antibody reactivity tests in less than a week, a throughput that is two orders of magnitude higher than that of traditional antibody detection assays such as enzyme-linked immunosorbent assays and immunofluorescence. Using a limited number of mice, we can develop a vast repertoire of mAbs directed against nuclear and surface proteins of several human and avian influenza virus strains. © 2010 Nature America, Inc. All rights reserved.
Cite
CITATION STYLE
Di Cristina, M., Nunziangeli, L., Giubilei, M. A., Capuccini, B., D’Episcopo, L., Mazzoleni, G., … Crisanti, A. (2010). An antigen microarray immunoassay for multiplex screening of mouse monoclonal antibodies. Nature Protocols, 5(12), 1932–1944. https://doi.org/10.1038/nprot.2010.161
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.